(Q53591453)

16 May 2018

title

Quality of life in young patients with chronic myelocytic leukaemia during intensive treatment including interferon. (English)

1 reference

16 May 2018

1 reference

1 reference

Stalfelt AM

1

1 reference

16 May 2018

Zettervall O

series ordinal

2

1 reference

16 May 2018

publication date

1 August 1997

1 reference

16 May 2018

published in

Leukemia Research

1 reference

16 May 2018

volume

21

1 reference

16 May 2018

issue

8

1 reference

16 May 2018

page(s)

775-783

1 reference

16 May 2018

Options for therapy in chronic myeloid leukaemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Quality of life of patients with acute myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Physicians' attitudes toward clinical trials and their relationship to patient accrual in a Nordic multicenter study on myeloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Longitudinal study on the Quality of Life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

Quality of life during induction treatment of acute myeloid leukaemia. A comparison of three intensive chemotherapy regimens using three instruments for quality of life assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

The quality of life in adult survivors of allogeneic bone marrow transplantation. Correlates and comparison with matched renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2897%2900026-X

7 January 2021

10.1016/S0145-2126(97)00026-X

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018